This study was designed to address the feasibility of detection of fetal ce
lls with chromosome abnormalities in maternal blood. Peripheral venous bloo
d samples were collected from 150 pregnant women 1 day to 8 weeks before in
vasive examinations (amniocentesis, chorionic villus sampling, or fetal blo
od sampling). Fetal nucleated red blood cells were isolated by using a trip
le-density gradient followed by magnetic-activated cell sorting to select C
D71 cells. Fluorescence in situ hybridization (FISH) with probes specific f
or chromosomes X, Y, 13, 18, and 21 was used to detect fetal cells from ane
uploid pregnancies. The hybridization efficiency was greater than 98% for e
ach probe in normal controls, and approximately 20% of all cells failed to
hybridize after magnetic-activated cell sorting. Of the 10 aneuploid pregna
ncies identified with invasive procedures, trisomic fetal cells were identi
fied in eight. The frequency of fetal cells in the sorted specimens ranged
from 0 to 223 per 10,000 maternal nucleated cells. Although the aneuploid f
etal cells could be successfully detected in eight of 10 patients in the cu
rrent study, the existence of some limiting factors, such as scarcity of fe
tal cells and poor hybridization efficiency of FISH, raises questions about
its clinical suitability for routine use.